Viewing data from:

HYDROCORTISONE VALERATE

ANDA

HYDROCORTISONE VALERATE | A075043 | SUN PHARMA CANADA INC

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 3 NDCs

Highest NADAC/Unit

$2.09

per gm

Lowest NADAC/Unit

$1.14

per gm

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
51672129201HYDROCORTISONE VAL 0.2% OINTMT	$2.09	GM	Generic	—	2026-06-17
51672129206HYDROCORTISONE VAL 0.2% OINTMT	$1.62	GM	Generic	—	2026-06-17
51672129203HYDROCORTISONE VAL 0.2% OINTMT	$1.14	GM	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 3 NDCs (3 FSS)

Lowest Price

$59.50

Highest Price

$128.62

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
51672-1292-01HYDROCORTISONE VALERATE 0.2% OINT,USP,TOP	$59.50	FSS	Golden State Medical Supply, Inc.	06/14/2028
51672-1292-03HYDROCORTISONE VALERATE 0.2% OINT,USP,TOP	$128.62	FSS	Golden State Medical Supply, Inc.	06/14/2028
51672-1292-06HYDROCORTISONE VALERATE 0.2% OINT,TOP	$105.76	FSS	Golden State Medical Supply, Inc.	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain3 active DMFs1 inactive

3 active API suppliers hold Drug Master Files for this ingredient.

LUPIN LTDHYDROCORTISONE VALERATE USP

DMF 311432016

SYMBIOTICA SPECIALITY INGREDIENTS SDN BHDHYDROCORTISONE VALERATE USP

DMF 314232017

TRIFARMA SPAHYDROCORTISONE VALERATE

DMF 333342018

YANGZHOU PHARMACEUTICAL CO LTDInactiveHYDROCORTISONE VALERATE USP

DMF 309712016

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Aug 25, 1998	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 0.2%

0 patents0 exclusivities▴

OINTMENT;TOPICAL | Approved: Aug 25, 1998

No patent or exclusivity listings for this strength.